Autopsy report · NCT05211141

Study to Evaluate Long Term Performance and Safety of the Knee Prosthesis (HLS KneeTec Deep Dish)

“the clinical data collected to date is sufficient for regulatory requirements”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 years 10 months after it had already started.
• Ran for about 5 years 10 months before it stopped.
• 119 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Corin

Sponsor type

Industry

Conditions

Total Knee Arthroplasty; Knee Disease; Total Knee Replacement; Osteo Arthritis Knee

Interventions

HLS KneeTec Deep Dish

Participants

119

Sites

1

Countries

France

Trials that died the same way

• Open Label Study to Collect Clinical Data to Document Clinical Performance and Safety in Total Knee Arthroplasty
  “the clinical data collected to date are sufficient for regulatory requirements” (100% match in meaning)
• Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma
  “Based on FDA requirements” (62% match in meaning)
• Novel Interventions in HIV-1 Infection
  “Data from the 12 patients recruited has now been analysed, and it has been determined that it is sufficient to meet the study objectives.” (61% match in meaning)
• Craniomaxillofacial Allotransplantation
  “It was determined that the study would be integrated into the standard clinical care.” (58% match in meaning)
• DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)
  “FDA Clinical Hold as of 12/21/07 due to safety concerns” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.